Abstract:The APOBEC3 deoxycytidine deaminase family functions as host restriction factors that can block replication of Vif (virus infectivity factor) deficient HIV-1 virions to differing degrees by deaminating cytosines to uracils in single-stranded (-)HIV-1 DNA. Upon replication of the (-)DNA to (+)DNA, the HIV-1 reverse transcriptase incorporates adenines opposite the uracils, thereby inducing C/G→T/A mutations that can functionally inactivate HIV-1. Although both APOBEC3F and APOBEC3G are expressed in cell types HIV-1 infects and are suppressed by Vif, there has been no prior biochemical analysis of APOBEC3F, in contrast to APOBEC3G. Using synthetic DNA substrates, we characterized APOBEC3F and found that similar to APOBEC3G; it is a processive enzyme and can deaminate at least two cytosines in a single enzyme-substrate encounter. However, APOBEC3F scanning movement is distinct from APOBEC3G, and relies on jumping rather than both jumping and sliding. APOBEC3F jumping movements were also different from APOBEC3G. The lack of sliding movement from APOBEC3F is due to an ¹⁹⁰NPM¹⁹² motif, since insertion of this motif into APOBEC3G decreases its sliding movements. The APOBEC3G NPM mutant induced significantly less mutations in comparison to wild-type APOBEC3G in an in vitro model HIV-1 replication assay and single-cycle infectivity assay, indicating that differences in DNA scanning were relevant to restriction of HIV-1. Conversely, mutation of the APOBEC3F ¹⁹¹Pro to ¹⁹¹Gly enables APOBEC3F sliding movements to occur. Although APOBEC3F ¹⁹⁰NGM¹⁹² could slide, the enzyme did not induce more mutagenesis than wild-type APOBEC3F, demonstrating that the unique jumping mechanism of APOBEC3F abrogates the influence of sliding on mutagenesis. Overall, we demonstrate key differences in the impact of APOBEC3F- and APOBEC3G-induced mutagenesis on HIV-1 that supports a model in which both the processive DNA scanning mechanism and preferred deamination motif (APOBEC3F, 5'TTC; APOBEC3G 5'CCC) influences the mutagenic and gene inactivation potential of an APOBEC3 enzyme.

Small‐Molecule APOBEC3G DNA Cytosine Deaminase Inhibitors Based on a 4‐amino‐1,2,4‐triazole‐3‐thiol Scaffold

USP49 Potently Stabilizes APOBEC3G Protein by Removing Ubiquitin and Inhibits HIV-1 Replication

Cytidine Deaminases APOBEC3G and APOBEC3F Interact with Human Immunodeficiency Virus Type 1 Integrase and Inhibit Proviral DNA Formation

Aromatic disulfides as potential inhibitors against interaction between deaminase APOBEC3G and HIV infectivity factor

Crystal Structure of the C-terminal Deaminase Domain of APOBEC3G: Implications and Projections

Next generation APOBEC3 inhibitors: Optimally designed for potency and nuclease stability

Different Mutagenic Potential of HIV-1 Restriction Factors APOBEC3G and APOBEC3F Is Determined by Distinct Single-Stranded DNA Scanning Mechanisms

Functional analysis of the two cytidine deaminase domains in APOBEC3G.

Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer

Various strategies for developing APOBEC3G protectors to circumvent human immunodeficiency virus type 1

APOBEC proteins and intrinsic resistance to HIV-1 infection

Reduced Apobec3h Variant Anti-Viral Activities Are Associated With Altered Rna Binding Activities

Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1.

Molecular mechanism for regulating APOBEC3G DNA editing function by the non-catalytic domain

APOBEC3s: DNA‐editing human cytidine deaminases

The APOBEC3 Family of Retroelement Restriction Factors

Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and Mc Modification.

The Disassociation of A3G-Related HIV-1 cDNA G-to-A Hypermutation to Viral Infectivity

Nanoscale Characterization of Interaction of APOBEC3G with RNA.

Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA